Cargando…
Lung cancer screening in the gulf: Rationale and recommendations
Lung cancer is the leading cause of cancer-related death worldwide among both men and women. Although advances in therapy have been made, the 5-year survival rates for lung cancer remain poor, ranging from 10% to 20%. One of the main reasons is late presentation, as only 25% of patients are amenable...
Autores principales: | Bennji, Sami M., Jayakrishnan, B., Al-Kindi, Adil H., Al-Jahdhami, Issa, Al-Hashami, Zamzam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662086/ https://www.ncbi.nlm.nih.gov/pubmed/36387753 http://dx.doi.org/10.4103/atm.atm_69_22 |
Ejemplares similares
-
Respiratory Complications after COVID-19
por: Al-Jahdhami, Issa, et al.
Publicado: (2022) -
Cheerios sign: A rare sign on chest computed tomography
por: Bennji, S M, et al.
Publicado: (2022) -
Bleomycin and perioperative care: A case report
por: Jayakrishnan, B, et al.
Publicado: (2023) -
The Gulf Familial Hypercholesterolemia Registry (Gulf FH): Design, Rationale and Preliminary Results
por: Al-Rasadi, Khalid, et al.
Publicado: (2020) -
Real-world eligibility for platinum doublet plus immune checkpoint inhibitors in extensive-stage small-cell lung cancer
por: Rittberg, Rebekah, et al.
Publicado: (2022)